#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	19	16638	16S	1529	1529	100.0	16S.l15.c4.ctg.1	2005	820.9	1	SNP	n	C1184T	0	.	.	1184	1184	C	1415	1415	C	998	C	939	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	29508	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3630	810.3	0	.	n	.	0	T695C	SNP	695	695	T	1043	1043	C	877	C	818	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	29508	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3630	810.3	0	.	n	.	0	A1638G	SNP	1638	1638	A	1986	1986	G	982	G,A	912,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	29508	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3630	810.3	0	.	n	.	0	T1971C	SNP	1971	1971	T	2319	2319	C	889	C	825	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	29508	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3630	810.3	1	SNP	n	A2045G	0	.	.	2045	2045	A	2393	2393	A	933	A	871	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	29508	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3630	810.3	1	SNP	n	C2597T	0	.	.	2597	2597	C	2945	2945	C	869	C,T,A	815,1,1	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	29508	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3630	810.3	0	HET	.	.	.	A1072G	.	1072	1072	A	1420	1420	A	979	A,G	700,208	.	.
folP.WHO_O_01412c	folP.WHO_O_01412c	1	1	27	2154	folP	855	855	100.0	folP.l15.c4.ctg.1	1490	144.0	1	SNP	p	R229S	1	.	.	685	687	AGC	1030	1032	AGC	236;235;235	A;G;C	220;222;220	folP.WHO_O_01412c:1:1:R229S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	5626	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3307	169.1	1	SNP	p	S91F	1	.	.	271	273	TTC	599	601	TTC	178;178;179	T;T;C	164;162;164	gyrA.WHO_M_01098:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	5626	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3307	169.1	1	SNP	p	D95G	1	.	.	283	285	GGC	611	613	GGC	173;175;173	G;G;C	160;162;158	gyrA.WHO_M_01098:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	5626	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3307	169.1	1	SNP	p	G95N	0	.	.	283	285	GGC	611	613	GGC	173;175;173	G;G;C	160;162;158	gyrA.WHO_M_01098:1:1:G95N:gyrA.95N:Resistance to fluoroquinolones	.
mtrR.WHO_V_01454	mtrR.WHO_V_01454	1	1	539	1616	mtrR	633	633	97.31	mtrR.l15.c30.ctg.1	1253	128.4	0	.	p	.	0	V42I	NONSYN	124	126	GTA	432	434	ATA	207;210;212	A,G;T;A	186,1;184;191	.	.
mtrR.WHO_V_01454	mtrR.WHO_V_01454	1	1	539	1616	mtrR	633	633	97.31	mtrR.l15.c30.ctg.1	1253	128.4	0	.	p	.	0	D79N	NONSYN	235	237	GAT	543	545	AAT	244;241;241	A,G;A;T	225,1;223;220	.	.
mtrR.WHO_V_01454	mtrR.WHO_V_01454	1	1	539	1616	mtrR	633	633	97.31	mtrR.l15.c30.ctg.1	1253	128.4	0	.	p	.	0	G83E	NONSYN	247	249	GGT	555	557	GAA	226;226;230	G;A,G;A,T	214;210,1;213,1	.	.
mtrR.WHO_V_01454	mtrR.WHO_V_01454	1	1	539	1616	mtrR	633	633	97.31	mtrR.l15.c30.ctg.1	1253	128.4	0	.	p	.	0	Y105H	NONSYN	313	315	TAC	621	623	CAC	258;257;256	C;A;C	235;233;236	.	.
mtrR.WHO_V_01454	mtrR.WHO_V_01454	1	1	539	1616	mtrR	633	633	97.31	mtrR.l15.c30.ctg.1	1253	128.4	0	.	p	.	0	S183N	NONSYN	547	549	AGT	855	857	AAT	157;155;153	A;A;T	146;147;146	.	.
mtrR.WHO_V_01454	mtrR.WHO_V_01454	1	1	539	1616	mtrR	633	633	97.31	mtrR.l15.c30.ctg.1	1253	128.4	1	SNP	p	G45D	0	.	.	133	135	GGC	441	443	GGC	210;211;211	G;G;C	193;191;195	mtrR.WHO_V_01454:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5676	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2879	196.2	1	SNP	p	D86N	0	.	.	256	258	GAC	577	579	GAC	242;242;242	G;A;C	216;212;221	parC.WHO_Y_00247c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5676	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2879	196.2	1	SNP	p	R87W	0	.	.	259	261	CGT	580	582	CGT	240;241;240	C;G;T	218;218;219	parC.WHO_Y_00247c:1:1:R87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5676	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2879	196.2	1	SNP	p	S87R	1	.	.	259	261	CGT	580	582	CGT	240;241;240	C;G;T	218;218;219	parC.WHO_Y_00247c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5676	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2879	196.2	1	SNP	p	R87I	0	.	.	259	261	CGT	580	582	CGT	240;241;240	C;G;T	218;218;219	parC.WHO_Y_00247c:1:1:R87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5676	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2879	196.2	1	SNP	p	S88P	0	.	.	262	264	TCC	583	585	TCC	239;239;240	T;C;C,T	217;216;220,1	parC.WHO_Y_00247c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	4868	parE	1986	1986	100.0	parE.l15.c4.ctg.1	2649	182.9	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1533	1535	GGC	211;206;204	G;G;C	197;191;190	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.34.001	penA.34.001	1	1	27	4556	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2377	191.0	1	SNP	p	A311V	0	.	.	931	933	GCC	1293	1295	GCC	233;232;236	G;C;C	221;219;222	penA.34.001:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	4556	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2377	191.0	1	SNP	p	I312M	1	.	.	934	936	ATG	1296	1298	ATG	237;240;241	A;T;G	223;224;222	penA.34.001:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	4556	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2377	191.0	1	SNP	p	T316P	0	.	.	946	948	ACC	1308	1310	ACC	232;230;228	A;C,T;C,T	212;209,1;209,1	penA.34.001:1:1:T316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	4556	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2377	191.0	1	SNP	p	V316T	1	.	.	946	948	ACC	1308	1310	ACC	232;230;228	A;C,T;C,T	212;209,1;209,1	penA.34.001:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	4556	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2377	191.0	1	SNP	p	T483S	0	.	.	1447	1449	ACC	1809	1811	ACC	240;243;241	A;C;C	217;226;225	penA.34.001:1:1:T483S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	4556	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2377	191.0	1	SNP	p	A501P	0	.	.	1501	1503	GCG	1863	1865	GCG	242;243;244	G;C;G	228;226;226	penA.34.001:1:1:A501P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	4556	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2377	191.0	1	SNP	p	A501V	0	.	.	1501	1503	GCG	1863	1865	GCG	242;243;244	G;C;G	228;226;226	penA.34.001:1:1:A501V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	4556	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2377	191.0	1	SNP	p	G542S	0	.	.	1624	1626	GGT	1986	1988	GGT	212;211;212	G;G;T	197;195;190	penA.34.001:1:1:G542S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	4556	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2377	191.0	1	SNP	p	G545S	1	.	.	1633	1635	AGC	1995	1997	AGC	202;200;202	A;G;C	179;181;183	penA.34.001:1:1:G545S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	4556	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2377	191.0	1	SNP	p	P551S	0	.	.	1651	1653	CCG	2013	2015	CCG	172;174;176	C,G,T;C;G,A	123,6,1;126;128,1	penA.34.001:1:1:P551S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	27	6312	ponA	2397	2397	100.0	ponA.l15.c30.ctg.1	3047	206.1	1	SNP	p	L421P	1	.	.	1261	1263	CCG	1552	1554	CCG	194;195;194	C;C;G	171;180;172	ponA.WHO_G_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	2662	porA	1146	1146	99.91	porA.l6.c30.ctg.1	1685	156.6	0	.	p	.	0	M83fs	FSHIFT	247	247	A	514	514	C	167	C	155	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	3228	porB1b	1038	1038	97.21	porB1b.l15.c4.ctg.1	1520	210.8	0	.	p	.	0	I45V	NONSYN	133	135	ATT	417	419	GTT	252;252;252	G,T;T,G;T	236,1;233,1;237	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	3228	porB1b	1038	1038	97.21	porB1b.l15.c4.ctg.1	1520	210.8	0	.	p	.	0	I75V	NONSYN	223	225	ATT	507	509	GTT	271;273;281	G;T;T	246;239;254	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	3228	porB1b	1038	1038	97.21	porB1b.l15.c4.ctg.1	1520	210.8	0	.	p	.	0	S89T	NONSYN	265	267	AGC	549	551	ACC	274;271;273	A;C;C	248;250;255	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	3228	porB1b	1038	1038	97.21	porB1b.l15.c4.ctg.1	1520	210.8	0	.	p	.	0	I98V	NONSYN	292	294	ATC	576	578	GTC	266;266;266	G;T;C	245;240;249	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	3228	porB1b	1038	1038	97.21	porB1b.l15.c4.ctg.1	1520	210.8	0	.	p	.	0	A109V	NONSYN	325	327	GCC	609	611	GTC	258;259;259	G,A;T,C;C	232,1;226,1;234	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	3228	porB1b	1038	1038	97.21	porB1b.l15.c4.ctg.1	1520	210.8	0	.	p	.	0	F131Y	NONSYN	391	393	TTT	675	677	TAT	254;255;263	T;A,T;T	235;238,1;237	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	3228	porB1b	1038	1038	97.21	porB1b.l15.c4.ctg.1	1520	210.8	0	.	p	.	0	N134E	NONSYN	400	402	AAT	684	686	GAG	259;256;255	G;A;G	242;241;239	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	3228	porB1b	1038	1038	97.21	porB1b.l15.c4.ctg.1	1520	210.8	0	.	p	.	0	V135L	NONSYN	403	405	GTG	687	689	CTT	257;256;257	CTT,CT;T;T	241,1;241;242	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	3228	porB1b	1038	1038	97.21	porB1b.l15.c4.ctg.1	1520	210.8	0	.	p	.	0	G140K	NONSYN	418	420	GGA	702	704	AAA	255;252;256	A;A;A	244;238;242	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	3228	porB1b	1038	1038	97.21	porB1b.l15.c4.ctg.1	1520	210.8	0	.	p	.	0	Q143G	NONSYN	427	429	CAA	711	713	GGA	261;263;261	G;G;A	249;251;247	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	3228	porB1b	1038	1038	97.21	porB1b.l15.c4.ctg.1	1520	210.8	0	.	p	.	0	V151A	NONSYN	451	453	GTA	735	737	GCA	249;252;252	G;C,T;A	240;241,1;241	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	3228	porB1b	1038	1038	97.21	porB1b.l15.c4.ctg.1	1520	210.8	0	.	p	.	0	D171G	NONSYN	511	513	GAC	795	797	GGT	245;245;247	G;G,A;T,C	229;229,1;222,1	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	3228	porB1b	1038	1038	97.21	porB1b.l15.c4.ctg.1	1520	210.8	0	.	p	.	0	G210R	NONSYN	628	630	GGA	912	914	AGA	300;301;300	A;G,T;A	278;274,1;278	.	.
rpoB.WHO_M_02157	rpoB.WHO_M_02157	1	1	27	12136	rpoB	4179	4179	99.98	rpoB.l15.c4.ctg.1	4943	244.8	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	1272	rpsJ	312	312	100.0	rpsJ.l15.c4.ctg.1	937	134.3	1	SNP	p	V57M	1	.	.	169	171	ATG	451	453	ATG	274;274;278	A;T;G	258;259;262	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
